Cargando…

Drug metabolic activity is a critical cell-intrinsic determinant for selection of hepatocytes during long-term culture

BACKGROUND: The liver plays an important role in various metabolic processes, including protein synthesis, lipid and drug metabolisms and detoxifications. Primary culture of hepatocytes is used for the understanding of liver physiology as well as for the drug development. Hepatocytes are, however, h...

Descripción completa

Detalles Bibliográficos
Autores principales: Akiyama, Saeko, Saku, Noriaki, Miyata, Shoko, Ite, Kenta, Toyoda, Masashi, Kimura, Tohru, Kuroda, Masahiko, Nakazawa, Atsuko, Kasahara, Mureo, Nonaka, Hidenori, Kamiya, Akihide, Kiyono, Tohru, Kobayshi, Tohru, Murakami, Yasufumi, Umezawa, Akihiro
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8917760/
https://www.ncbi.nlm.nih.gov/pubmed/35279203
http://dx.doi.org/10.1186/s13287-022-02776-5
_version_ 1784668617954033664
author Akiyama, Saeko
Saku, Noriaki
Miyata, Shoko
Ite, Kenta
Toyoda, Masashi
Kimura, Tohru
Kuroda, Masahiko
Nakazawa, Atsuko
Kasahara, Mureo
Nonaka, Hidenori
Kamiya, Akihide
Kiyono, Tohru
Kobayshi, Tohru
Murakami, Yasufumi
Umezawa, Akihiro
author_facet Akiyama, Saeko
Saku, Noriaki
Miyata, Shoko
Ite, Kenta
Toyoda, Masashi
Kimura, Tohru
Kuroda, Masahiko
Nakazawa, Atsuko
Kasahara, Mureo
Nonaka, Hidenori
Kamiya, Akihide
Kiyono, Tohru
Kobayshi, Tohru
Murakami, Yasufumi
Umezawa, Akihiro
author_sort Akiyama, Saeko
collection PubMed
description BACKGROUND: The liver plays an important role in various metabolic processes, including protein synthesis, lipid and drug metabolisms and detoxifications. Primary culture of hepatocytes is used for the understanding of liver physiology as well as for the drug development. Hepatocytes are, however, hardly expandable in vitro making it difficult to secure large numbers of cells from one donor. Alternatively, systems using animal models and hepatocellular carcinoma cells have been established, but interspecies differences, variation between human cell sources and limited hepatic functions are among the challenges faced when using these models. Therefore, there is still a need for a highly stable method to purify human hepatocytes with functional sufficiency. In this study, we aimed to establish an in vitro long-term culture system that enables stable proliferation and maintenance of human hepatocytes to ensure a constant supply. METHODS: We first established a growth culture system for hepatocytes derived from patients with drug-induced liver injury using fetal mouse fibroblasts and EMUKK-05 medium. We then evaluated the morphology, proliferative capacity, chromosome stability, gene and protein expression profiles, and drug metabolic capacity of hepatocytes in early, middle and late passages with and without puromycin. In addition, hepatic maturation in 3D culture was evaluated from morphological and functional aspects. RESULTS: In our culture system, the stable proliferation of human hepatocytes was achieved by co-culturing with mouse fetal fibroblasts, resulting in dedifferentiation into hepatic progenitor-like cells. We purified human hepatocytes by selection with cytocidal puromycin and cultured them for more than 60 population doublings over a span of more than 350 days. Hepatocytes with high expression of cytochrome P450 genes survived after exposure to cytocidal antibiotics because of enhanced drug-metabolizing activity. CONCLUSIONS: These results show that this simple culture system with usage of the cytocidal antibiotics enables efficient hepatocyte proliferation and is an effective method for generating a stable supply of hepatocytes for drug discovery research at a significant cost reduction. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s13287-022-02776-5.
format Online
Article
Text
id pubmed-8917760
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-89177602022-03-21 Drug metabolic activity is a critical cell-intrinsic determinant for selection of hepatocytes during long-term culture Akiyama, Saeko Saku, Noriaki Miyata, Shoko Ite, Kenta Toyoda, Masashi Kimura, Tohru Kuroda, Masahiko Nakazawa, Atsuko Kasahara, Mureo Nonaka, Hidenori Kamiya, Akihide Kiyono, Tohru Kobayshi, Tohru Murakami, Yasufumi Umezawa, Akihiro Stem Cell Res Ther Research BACKGROUND: The liver plays an important role in various metabolic processes, including protein synthesis, lipid and drug metabolisms and detoxifications. Primary culture of hepatocytes is used for the understanding of liver physiology as well as for the drug development. Hepatocytes are, however, hardly expandable in vitro making it difficult to secure large numbers of cells from one donor. Alternatively, systems using animal models and hepatocellular carcinoma cells have been established, but interspecies differences, variation between human cell sources and limited hepatic functions are among the challenges faced when using these models. Therefore, there is still a need for a highly stable method to purify human hepatocytes with functional sufficiency. In this study, we aimed to establish an in vitro long-term culture system that enables stable proliferation and maintenance of human hepatocytes to ensure a constant supply. METHODS: We first established a growth culture system for hepatocytes derived from patients with drug-induced liver injury using fetal mouse fibroblasts and EMUKK-05 medium. We then evaluated the morphology, proliferative capacity, chromosome stability, gene and protein expression profiles, and drug metabolic capacity of hepatocytes in early, middle and late passages with and without puromycin. In addition, hepatic maturation in 3D culture was evaluated from morphological and functional aspects. RESULTS: In our culture system, the stable proliferation of human hepatocytes was achieved by co-culturing with mouse fetal fibroblasts, resulting in dedifferentiation into hepatic progenitor-like cells. We purified human hepatocytes by selection with cytocidal puromycin and cultured them for more than 60 population doublings over a span of more than 350 days. Hepatocytes with high expression of cytochrome P450 genes survived after exposure to cytocidal antibiotics because of enhanced drug-metabolizing activity. CONCLUSIONS: These results show that this simple culture system with usage of the cytocidal antibiotics enables efficient hepatocyte proliferation and is an effective method for generating a stable supply of hepatocytes for drug discovery research at a significant cost reduction. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s13287-022-02776-5. BioMed Central 2022-03-12 /pmc/articles/PMC8917760/ /pubmed/35279203 http://dx.doi.org/10.1186/s13287-022-02776-5 Text en © The Author(s) 2022 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
spellingShingle Research
Akiyama, Saeko
Saku, Noriaki
Miyata, Shoko
Ite, Kenta
Toyoda, Masashi
Kimura, Tohru
Kuroda, Masahiko
Nakazawa, Atsuko
Kasahara, Mureo
Nonaka, Hidenori
Kamiya, Akihide
Kiyono, Tohru
Kobayshi, Tohru
Murakami, Yasufumi
Umezawa, Akihiro
Drug metabolic activity is a critical cell-intrinsic determinant for selection of hepatocytes during long-term culture
title Drug metabolic activity is a critical cell-intrinsic determinant for selection of hepatocytes during long-term culture
title_full Drug metabolic activity is a critical cell-intrinsic determinant for selection of hepatocytes during long-term culture
title_fullStr Drug metabolic activity is a critical cell-intrinsic determinant for selection of hepatocytes during long-term culture
title_full_unstemmed Drug metabolic activity is a critical cell-intrinsic determinant for selection of hepatocytes during long-term culture
title_short Drug metabolic activity is a critical cell-intrinsic determinant for selection of hepatocytes during long-term culture
title_sort drug metabolic activity is a critical cell-intrinsic determinant for selection of hepatocytes during long-term culture
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8917760/
https://www.ncbi.nlm.nih.gov/pubmed/35279203
http://dx.doi.org/10.1186/s13287-022-02776-5
work_keys_str_mv AT akiyamasaeko drugmetabolicactivityisacriticalcellintrinsicdeterminantforselectionofhepatocytesduringlongtermculture
AT sakunoriaki drugmetabolicactivityisacriticalcellintrinsicdeterminantforselectionofhepatocytesduringlongtermculture
AT miyatashoko drugmetabolicactivityisacriticalcellintrinsicdeterminantforselectionofhepatocytesduringlongtermculture
AT itekenta drugmetabolicactivityisacriticalcellintrinsicdeterminantforselectionofhepatocytesduringlongtermculture
AT toyodamasashi drugmetabolicactivityisacriticalcellintrinsicdeterminantforselectionofhepatocytesduringlongtermculture
AT kimuratohru drugmetabolicactivityisacriticalcellintrinsicdeterminantforselectionofhepatocytesduringlongtermculture
AT kurodamasahiko drugmetabolicactivityisacriticalcellintrinsicdeterminantforselectionofhepatocytesduringlongtermculture
AT nakazawaatsuko drugmetabolicactivityisacriticalcellintrinsicdeterminantforselectionofhepatocytesduringlongtermculture
AT kasaharamureo drugmetabolicactivityisacriticalcellintrinsicdeterminantforselectionofhepatocytesduringlongtermculture
AT nonakahidenori drugmetabolicactivityisacriticalcellintrinsicdeterminantforselectionofhepatocytesduringlongtermculture
AT kamiyaakihide drugmetabolicactivityisacriticalcellintrinsicdeterminantforselectionofhepatocytesduringlongtermculture
AT kiyonotohru drugmetabolicactivityisacriticalcellintrinsicdeterminantforselectionofhepatocytesduringlongtermculture
AT kobayshitohru drugmetabolicactivityisacriticalcellintrinsicdeterminantforselectionofhepatocytesduringlongtermculture
AT murakamiyasufumi drugmetabolicactivityisacriticalcellintrinsicdeterminantforselectionofhepatocytesduringlongtermculture
AT umezawaakihiro drugmetabolicactivityisacriticalcellintrinsicdeterminantforselectionofhepatocytesduringlongtermculture